Scilex Holding (SCLX) Intangibles (2021 - 2026)

Scilex Holding (SCLX) posted quarterly Intangibles of $59.8 million for Q1 2026, down 1.6% year-over-year from $60.8 million in Q1 2025, and down 34.84% on a QoQ basis from $91.8 million in Q4 2025.

Scilex Holding (SCLX) Intangibles (2021 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Intangibles for 6 consecutive years, with $59.8 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Intangibles fell 1.6% year-over-year to $59.8 million; the TTM figure through Mar 2026 stood at $59.8 million (down 1.6% YoY), while the FY2025 annual figure was $91.8 million, up 51.0% from the prior year.
  • Intangibles came in at $59.8 million for Q1 2026 at Scilex Holding, down from $91.8 million in the prior quarter.
  • The five-year high for Intangibles was $91.8 million in Q4 2025, with the low at $5.0 million in Q1 2022.
  • Average Intangibles over 5 years is $42.2 million, with a median of $38.5 million recorded in 2023.
  • Across the five-year window, Intangibles surged 1115.62% in 2023 and slumped 48.27% in 2025, its largest moves.
  • Year by year, Intangibles stood at $40.6 million in 2022, then soared by 49.74% to $60.8 million in 2023, then changed by 0.0% to $60.8 million in 2024, then surged by 51.0% to $91.8 million in 2025, then slumped by 34.84% to $59.8 million in 2026.
  • According to Business Quant data, Intangibles over the past three periods registered $59.8 million, $91.8 million, and $30.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 7.37 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 49.06 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 50.87 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 36.91 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 25.75 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 21.38 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 16.38 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 52.56 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - 11.30 Bn
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn 59.81 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 59.81 Mn
Dec 31, 2025 91.78 Mn
Sep 30, 2025 30.42 Mn
Jun 30, 2025 31.44 Mn
Mar 31, 2025 60.78 Mn
Dec 31, 2024 60.78 Mn
Sep 30, 2024 33.45 Mn
Jun 30, 2024 60.78 Mn
Mar 31, 2024 35.46 Mn
Dec 31, 2023 60.78 Mn
Sep 30, 2023 37.51 Mn
Jun 30, 2023 38.54 Mn
Mar 31, 2023 60.78 Mn
Dec 31, 2022 40.59 Mn
Sep 30, 2022 5.00 Mn
Jun 30, 2022 5.00 Mn
Mar 31, 2022 5.00 Mn
Dec 31, 2021 38.80 Mn